Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis
Patients with diffuse large B-cell lymphoma (DLBCL) are treated with rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). The role of consolidative radiation therapy (RT) remains unclear among patients with advanced DLBCL who achieved complete remission...
Main Authors: | Kyu-Hye Choi, Seung-Jae Lee, So-Hwa Mun, Jin-Ho Song, Byung-Ock Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/15/3940 |
Similar Items
-
Sciatic diffuse large B-cell lymphoma with treatment response to CHOP and radiotherapy
by: Firoozeh Shomal Zadeh, MD, et al.
Published: (2024-01-01) -
Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma
by: Esther Hian Li Chan, et al.
Published: (2019-08-01) -
Body Composition as a Predictor of Toxicity and Prognosis in Patients with Diffuse Large B-Cell Lymphoma Receiving R-CHOP Immunochemotherapy
by: Jiaxun Guo, et al.
Published: (2021-03-01) -
Infradiaphragmal Radiotherapy in Patients with Lymphoma: Volume Definition and Side Effects
by: Lea Galunić Bilić, et al.
Published: (2018-01-01) -
Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
by: Clemens Seidel, et al.
Published: (2021-05-01)